Children with high-functioning ASDs (HFASDs) are characterized by core impairments in social-communication including deficits in recognition (decoding) and display (encoding) of facial and vocal emotions and expressions. The purpose of this randomized clinical trial is to evaluate the efficacy of an innovative multi-component manualized treatment on the emotion recognition skills and autism features of 7-12 year old children with HFASDs. Treatment is administered during 24 90-minute sessions (over 3 months) and active components include an interactive emotion-recognition software program (Mind Reading; MR), in vivo rehearsal trials, and a structured behavioral reinforcement system. Each treatment session is manualized to ensure implementation is standardized, participants meet time parameters using and accessing areas of MR, content is prescribed, and fidelity is monitored and maintained. Outcome measures consist of a direct child measure of emotion recognition skills, a parent rating scale assessing child emotion recognition and display skills, a parent rating scale assessing autism features, and parent and child satisfaction surveys. A 1-2 month follow-up is used to assess skill generalization and maintenance.